Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Palmitoylethanolamide Protects Against the Amyloid-β25-35-Induced Learning and Memory Impairment in Mice, an Experimental Model of Alzheimer Disease
Giuseppe D’Agostino, Roberto Russo, Carmen Avagliano, et al.
Neuropsychopharmacology (2012) Vol. 37, Iss. 7, pp. 1784-1792
Open Access | Times Cited: 139

Showing 1-25 of 139 citing articles:

Cannabinoids and the expanded endocannabinoid system in neurological disorders
Luigia Cristino, Tiziana Bisogno, Vincenzo Di Marzo
Nature Reviews Neurology (2019) Vol. 16, Iss. 1, pp. 9-29
Closed Access | Times Cited: 779
An update on PPAR activation by cannabinoids
Saoirse E. O’Sullivan
British Journal of Pharmacology (2016) Vol. 173, Iss. 12, pp. 1899-1910
Open Access | Times Cited: 403
Endocannabinoids and endocannabinoid-related mediators: Targets, metabolism and role in neurological disorders
Fabio Arturo Iannotti, Vincenzo Di Marzo, Stefania Petrosino
Progress in Lipid Research (2016) Vol. 62, pp. 107-128
Closed Access | Times Cited: 324
The pharmacology of palmitoylethanolamide and first data on the therapeutic efficacy of some of its new formulations
Stefania Petrosino, Vincenzo Di Marzo
British Journal of Pharmacology (2016) Vol. 174, Iss. 11, pp. 1349-1365
Open Access | Times Cited: 275
Assessment of disease-related cognitive impairments using the novel object recognition (NOR) task in rodents
B. Terence Grayson, Marianne Léger, Chloe Piercy, et al.
Behavioural Brain Research (2014) Vol. 285, pp. 176-193
Closed Access | Times Cited: 207
The dynamics of monocytes and microglia in Alzheimer’s disease
Peter Thériault, Ayman ElAli, Serge Rivest
Alzheimer s Research & Therapy (2015) Vol. 7, Iss. 1
Open Access | Times Cited: 200
Neuroinflammation, Microglia and Mast Cells in the Pathophysiology of Neurocognitive Disorders: A Review
Stephen D. Skaper, Laura Facci, Pietro Giusti
CNS & Neurological Disorders - Drug Targets (2015) Vol. 13, Iss. 10, pp. 1654-1666
Closed Access | Times Cited: 152
Palmitoylethanolamide in CNS health and disease
Giuseppina Mattace Raso, Roberto Russo, Antonio Calignano, et al.
Pharmacological Research (2014) Vol. 86, pp. 32-41
Closed Access | Times Cited: 137
Palmitoylethanolamide Is a Disease-Modifying Agent in Peripheral Neuropathy: Pain Relief and Neuroprotection Share a PPAR-Alpha-Mediated Mechanism
Lorenzo Di Cesare Mannelli, Giuseppe D’Agostino, Alessandra Pacini, et al.
Mediators of Inflammation (2013) Vol. 2013, pp. 1-12
Open Access | Times Cited: 126
Glia and Mast Cells as Targets for Palmitoylethanolamide, an Anti-inflammatory and Neuroprotective Lipid Mediator
Stephen D. Skaper, Laura Facci, Pietro Giusti
Molecular Neurobiology (2013) Vol. 48, Iss. 2, pp. 340-352
Closed Access | Times Cited: 122
Down regulation of pro-inflammatory pathways by tanshinone IIA and cryptotanshinone in a non-genetic mouse model of Alzheimer’s disease
Francesco Μaione, Marialuisa Piccolo, Simona De Vita, et al.
Pharmacological Research (2017) Vol. 129, pp. 482-490
Closed Access | Times Cited: 115
Neutralization of IL‐17 rescues amyloid‐β‐induced neuroinflammation and memory impairment
Claudia Cristiano, Floriana Volpicelli, Pellegrino Lippiello, et al.
British Journal of Pharmacology (2019) Vol. 176, Iss. 18, pp. 3544-3557
Open Access | Times Cited: 114
Mast cell–glia axis in neuroinflammation and therapeutic potential of the anandamide congener palmitoylethanolamide
Stephen D. Skaper, Laura Facci
Philosophical Transactions of the Royal Society B Biological Sciences (2012) Vol. 367, Iss. 1607, pp. 3312-3325
Open Access | Times Cited: 111
Molecular evidence for the involvement of PPAR-δ and PPAR-γ in anti-inflammatory and neuroprotective activities of palmitoylethanolamide after spinal cord trauma
Irene Paterniti, Daniela Impellizzeri, Rosalia Crupi, et al.
Journal of Neuroinflammation (2013) Vol. 10, Iss. 1
Open Access | Times Cited: 104
N ‐Acylethanolamine‐hydrolyzing acid amidase inhibition increases colon N ‐palmitoylethanolamine levels and counteracts murine colitis
Mireille Alhouayek, Pauline Bottemanne, Kumar V. Subramanian, et al.
The FASEB Journal (2014) Vol. 29, Iss. 2, pp. 650-661
Open Access | Times Cited: 96
Palmitoylethanolamide: A Natural Compound for Health Management
Paul Clayton, Mariko Hill, Nathasha Bogoda, et al.
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 10, pp. 5305-5305
Open Access | Times Cited: 89
Antiepileptic action of N-palmitoylethanolamine through CB1 and PPAR-α receptor activation in a genetic model of absence epilepsy
Rita Citraro, Emilio Russo, Francesca Scicchitano, et al.
Neuropharmacology (2012) Vol. 69, pp. 115-126
Closed Access | Times Cited: 94
Palmitoylethanolamide in Homeostatic and Traumatic Central Nervous System Injuries
Emanuela Esposito, Salvatore Cuzzocrea
CNS & Neurological Disorders - Drug Targets (2013) Vol. 12, Iss. 1, pp. 55-61
Closed Access | Times Cited: 92
Antineuropathic Profile of N-Palmitoylethanolamine in a Rat Model of Oxaliplatin-Induced Neurotoxicity
Lorenzo Di Cesare Mannelli, Alessandra Pacini, Francesca Corti, et al.
PLoS ONE (2015) Vol. 10, Iss. 6, pp. e0128080-e0128080
Open Access | Times Cited: 87
Behavioral Phenotyping for Autism Spectrum Disorders in Mice
Yu‐Chi Chang, Toby B. Cole, Lucio G. Costa
Current Protocols in Toxicology (2017) Vol. 72, Iss. 1
Open Access | Times Cited: 80
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer’s disease by exerting anti-inflammatory and neuroprotective effects
Caterina Scuderi, Maria Rosanna Bronzuoli, Roberta Facchinetti, et al.
Translational Psychiatry (2018) Vol. 8, Iss. 1
Open Access | Times Cited: 74
Oral Ultramicronized Palmitoylethanolamide: Plasma and Tissue Levels and Spinal Anti-hyperalgesic Effect
Stefania Petrosino, Marika Cordaro, Roberta Verde, et al.
Frontiers in Pharmacology (2018) Vol. 9
Open Access | Times Cited: 74
Palmitoylethanolamide (PEA) as a Potential Therapeutic Agent in Alzheimer’s Disease
Sarah Beggiato, Maria Cristina Tomasini, Luca Ferraro
Frontiers in Pharmacology (2019) Vol. 10
Open Access | Times Cited: 74
Review of Alzheimer’s disease drugs and their relationship with neuron-glia interaction
Michael Kunle Ajenikoko, Abayomi Oyeyemi Ajagbe͓, Oluwanisola Onigbinde, et al.
IBRO Neuroscience Reports (2022) Vol. 14, pp. 64-76
Open Access | Times Cited: 29
Isolation and characterization of N‐(2‐Hydroxyethyl)hexadecanamide from Colletotrichum gloeosporioides with apoptosis‐inducing potential in breast cancer cells
Nilesh Rai, Priyamvada Gupta, Ashish Verma, et al.
BioFactors (2023) Vol. 49, Iss. 3, pp. 663-683
Closed Access | Times Cited: 18
Page 1 - Next Page

Scroll to top